Patents by Inventor John Lau

John Lau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090026722
    Abstract: A system is disclosed for a baggage handling device to be placed between a weighing platform and a conveyor system at an airline check-in counter. The baggage handling device includes a cart portion further comprising a box frame, a set of wheels, a set of rollers, a latch mechanism and a set of handle rods, and a rail portion further comprising a rectangular frame with a set of rails and two sets of unlatch mechanisms. The set of wheels is aligned with and placed above the set of rails such that the cart portion moves along the rail portion. The latch mechanism is provided to facilitate a locked position to allow safe loading of baggage onto the cart portion.
    Type: Application
    Filed: July 28, 2007
    Publication date: January 29, 2009
    Applicant: MACTRONIX, INC.
    Inventor: John Lau
  • Publication number: 20070218117
    Abstract: The instant invention is drawn to a hepatocyte targeted composition comprising interferon associated with a supra-molecular lipid construct comprising amphipathic lipid molecules and receptor binding molecule. The composition can comprise a mixture of free interferon and interferon associated with the complex. The composition can be modified to protect interferon and the complex from degradation. The invention also includes methods for the manufacture of the composition and loading interferon into the composition and recycling various components of the composition. Methods of treating individuals infected with the hepatitis C and other hepatitis viruses.
    Type: Application
    Filed: March 20, 2006
    Publication date: September 20, 2007
    Inventors: John Lau, W. Geho
  • Publication number: 20070104777
    Abstract: A metal targeting complex which associates with a charged liposomal structure is provided. The metal targeting complex provides the targetability of the liposomal construct to the desired receptor sites of a warm-blooded host for therapy or diagnostic use.
    Type: Application
    Filed: December 21, 2006
    Publication date: May 10, 2007
    Inventors: John Lau, W. Geho, George Snedeker
  • Publication number: 20060222698
    Abstract: The instant invention is drawn to a hepatocyte targeted composition comprising a mixture of free glargine insulin and glargine insulin associated with a water insoluble target molecule complex, wherein the complex comprises multiple linked individual units and a supra-molecular lipid construct matrix. Glargine insulin is present within the complex in at least one form wherein the glargine insulin has a positive charge which interacts with a negative charge on the complex. The invention also includes methods for the manufacture of the composition and methods of managing blood glucose levels in individuals with Type I and Type II diabetes.
    Type: Application
    Filed: March 20, 2006
    Publication date: October 5, 2006
    Inventors: John Lau, W. Geho
  • Publication number: 20060222697
    Abstract: The instant invention is drawn to a hepatocyte targeted composition comprising a mixture of free recombinant human insulin isophane and free Recombinant human regular insulin insulin and a mixture of recombinant human insulin isophane and Recombinant human regular insulin insulin associated with a water insoluble target molecule complex, wherein the complex comprises multiple linked individual units and a supra-molecular lipid construct matrix. Recombinant human insulin isophane and Recombinant human regular insulin insulin are present within the complex in at least one form wherein the recombinant human insulin isophane and Recombinant human regular insulin insulin have regions of positive charge which interacts with a negative charge on the complex. The invention also includes methods for the manufacture of the composition and methods of managing blood glucose levels in individuals with Type I and Type II diabetes.
    Type: Application
    Filed: March 20, 2006
    Publication date: October 5, 2006
    Inventors: John Lau, W. Geho
  • Publication number: 20050245642
    Abstract: Glass formulations, and a method of converting such glass formulations to glass beads having a refractive index of at least 1.59 and a high level of retroreflectivity, are provided. The methods and formulations provide beads also having high levels of resistance to degradation by environmental exposure.
    Type: Application
    Filed: April 28, 2004
    Publication date: November 3, 2005
    Inventors: Ufuk Senturk, Michael Lanci, Raymond Jackson, John Lau